Ledger.Open graph →
SEC Form D · Amendment · filed May 28, 2020

Nautilus Biotechnology, Inc

Offering
$76.1M
Sold
$76.1M
Exemption
Rule 506(b)
Industry
Other
Location
San Carlos, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Matthew Posard · San Carlos, CADirectorAshley Thompson · Chicago, ILDirectorMatt Mulherin · Rogers, ARDirectorStuart Nagae · San Carlos, CADirectorTrinda Blackmore · Grand Cayman, Cayman IslandsDirectorTerry Knoploh · Rogers, ARDirectorMeagan Bowman · Rogers, ARExec · DirectorFarzad Nazem · San Carlos, CADirectorGuillermo Freile · Chicago, ILDirectorParag Mallick · San Carlos, CADirectorRichard Jacinto Ii · RICHMOND, British Columbia, CanadaDirectorVijay Pande · San Carlos, CADirectorTodd Asmuth · New York, NYExec · DirectorSam Mcbride · Chicago, ILDirectorMatthew A. Mccall · Conway, SCDirectorSujal Patel · San Carlos, CAExec · DirectorJay C. Hoag · Menlo Park, CADirectorKhang Ting · HONG KONG, Hong KongDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗